HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identifying sequential episodes of pharmacotherapy as a method for assessing treatment failure in comparative effectiveness research.

AbstractPURPOSE:
To describe and implement a novel method of measuring comparative effectiveness using sequential episodes of pharmacotherapy as a proxy for treatment failure.
METHODS:
Retrospective cohort study using linked deidentified data from the British Columbia Ministry of Health during a government-sponsored smoking cessation reimbursement program.Three study cohorts were created based on first use of varenicline, bupropion, or nicotine replacement therapy (NRT), for adults aged 18 or older, in the period September 30th, 2011 to March 31st, 2013. The study cohorts were analyzed for sequential episodes of pharmacotherapy, defined as re-initiating a smoking cessation pharmacotherapy after an initial episode of treatment and washout period. The statistical analysis used propensity score adjusted log-binomial regression models with one-year and two-year fixed follow-up after a 12-week washout period. A sensitivity analysis excluded the washout period. A secondary analysis investigated predictors of receiving a sequential episode of smoking cessation pharmacotherapy RESULTS: 116,442 participants of the B.C. Smoking Cessation Program were analyzed. Compared to NRT, varenicline users were 13% less likely, and bupropion users were 18% less likely, to re-start smoking cessation therapy within 1-year after an initial course of treatment.
CONCLUSIONS:
Sequential episodes of pharmacotherapy identified treatment failures to smoking cessation therapy. Based on sequential episodes of pharmacotherapy during a drug benefit policy of smoking cessation medications, varenicline and bupropion were more effective aids to smoking cessation than NRT. The method was also used to identify patient characteristics associated with treatment effectiveness.
AuthorsGreg Carney, Malcolm Maclure, Ken Bassett, Suzanne Taylor, Colin R Dormuth
JournalPharmacoepidemiology and drug safety (Pharmacoepidemiol Drug Saf) Vol. 29 Issue 2 Pg. 199-207 (02 2020) ISSN: 1099-1557 [Electronic] England
PMID31793135 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2019 John Wiley & Sons, Ltd.
Chemical References
  • Smoking Cessation Agents
Topics
  • Adolescent
  • Adult
  • Aged
  • Cohort Studies
  • Comparative Effectiveness Research (methods)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Smoking Cessation (methods)
  • Smoking Cessation Agents (therapeutic use)
  • Tobacco Use Disorder (diagnosis, drug therapy, epidemiology)
  • Treatment Failure
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: